ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,285.71
1.21%
Dow Jones
40,589.34
1.64%
Gold vs US Dollar
2,387.035
0.00%
Brent Oil
79.745
0.00%
Bitcoin
67,800.01
-0.17%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. BioNTech SE (BNTX) Share Price

BNTX BioNTech SE

85.94
1.26 (1.49%)
26 Jul 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 BioNTech SE NASDAQ:BNTX NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   1.26 1.49 85.94 85.10 86.00 86.1423 84.92 85.05 265,281 22:55:57   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 3.82B 930.3M - N/A 20.13B
 Type  Size  Price  Time  Units 
 9 1 85.90 23:49:21 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore BNTX News
22/07/202411:45GLOBEBioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024
27/06/202415:30BWPfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
27/06/202415:30GLOBEPfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union  
24/06/202411:45GLOBEBioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer
17/06/202412:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
03/06/202412:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
01/06/202415:00GLOBEInvestigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
Period
Draw mode
Data Downloads for BNTX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest BioNTech SE Articles